Lucid Diagnostics Inc. Common Stock

LUCD

...

LUCD: Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Show LUCD Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of LUCD by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by LUCD's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on LUCD's company Twitter account

WallStreetBets

Number of mentions of LUCD in WallStreetBets Daily Discussion

LUCD News

Recent insights relating to LUCD

CNBC Recommendations

Recent picks made for LUCD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in LUCD

Corporate Flights

Flights by private jets registered to LUCD